Fonar Logo
diagnostic imaging management services

* FONAR is not responsible for the accuracy of information on these servers. This link is provided for your convenience only.

 

Fonar Financials Filed with the SEC

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

 

SEC Accession No. 0000355019-19-000040

Filing Date
2019-11-12
Accepted
2019-11-12 17:01:05
Documents
59
Period of Report
2019-09-30
 
Interactive Data
Document Format Files
Seq Description Document Type
1 FONAR CORPORATION 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2019 fonar_sep10-q.htm 10-Q
2 CERTIFICATION fonar_exhibit-31.htm EX-31.1
3 CERTIFICATION PURSUANT TO THE SARBANES-OXLEY ACT OF 2002 fonar_exhibit-32.htm EX-32.1
4 GRAPHIC fonar-logo.jpg GRAPHIC
  Complete submission text file 0000355019-19-000040.txt  

Data Files
Seq Description Document Type
5 XBRL INSTANCE FILE fonr-20190930.xml EX-101.INS
6 XBRL CALCULATION FILE fonr-20190930_cal.xml EX-101.CAL
7 XBRL DEFINITION FILE fonr-20190930_def.xml EX-101.DEF
8 XBRL LABEL FILE fonr-20190930_lab.xml EX-101.LAB
9 XBRL PRESENTATION FILE fonr-20190930_pre.xml EX-101.PRE
10 XBRL SCHEMA FILE fonr-20190930.xsd EX-101.SCH
       

FONAR CORPORATION (Filer) CIK: 0000355019

IRS No.: 112464137 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-10248 | Film No.: 191210571
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
Office of Life Sciences

Business Address

110 Marcus Drive
Melville, NY 11740
631-694-2929
Mailing Address

110 Marcus Drive
Melville, NY 11740